Session Type
Meeting
Search Results for Tobacco
Abstract Number: 214
SHM Converge 2024
Background: Tobacco cessation is the most effective intervention for reducing the progression of disease in COPD patients and reducing mortality. Varenicline is the most effective drug to treat tobacco use disorder. The American Thoracic Society strongly recommends initiation of Varenicline for smoking cessation, even in patients who are not ready to quit. Hospitalist initiation of […]
Abstract Number: 230
SHM Converge 2024
Background: Tobacco use is the most widespread preventable cause of cancer and is linked to 30% of cancer-related deaths.(1) Many smokers want to quit but are unsuccessful; tools such as nicotine replacement therapy (NRT) products can increase quit rates by 50-60%.(2) While smoking cessation is the ideal way to combat tobacco-related diseases, screening for diseases […]
Abstract Number: 263
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Inpatient hospitalization represents a key time for patients who use tobacco to quit smoking, and inpatients who receive smoking cessation counseling, nicotine replacement, and referral to outpatient resources have increased quit rates six weeks after hospital discharge. However, in 2014, only 34.5% of tobacco users admitted to our 600-bed academic hospital were documented as […]
Abstract Number: 313
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: The role of a hospitalist in treating nicotine withdrawal using counseling and medications during hospitalization can improve cessation rates of tobacco users. Clinical decision support and drug-condition alerts within the electronic medical record prompt the prescribing of medications for tobacco treatment and ease documentation of reimbursable counseling by physicians. Additionally, several hospitals have implemented […]
Abstract Number: 433
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Tobacco use remains the leading cause of preventable morbidity and mortality in the United States. Hospitalization is known to be an opportune time to initiate cessation interventions, and interventions with sustained postdischarge contact may increase the relative likelihood of cessation by 65% compared to usual care. Additionally, compared to physicians and nursing staff, clinical […]
Abstract Number: 460
Hospital Medicine 2020, Virtual Competition
Background: Hospitalization provides an opportunity to provide patients who use tobacco with evidence-based treatment for cessation, including nicotine replacement therapy, motivational interviewing, and pharmacotherapy. However, this benefit is often lost without appropriate transitions in care to outpatient cessation resources. We have found that inpatient tobacco cessation interventions at our 600-bed urban academic medical center do […]
Abstract Number: D14
SHM Converge 2022
Background: United States Preventive Services Task Force recommends clinicians provide smoking cessation counseling and interventions to all smokers and lung cancer screening with low dose CT scan for high-risk individuals. We aimed to determine the prevalence of smoking cessation counseling and lung cancer screening rate at the residents’ clinic and implement a multimodal plan to […]